Are pathogenic BRCA1 mutations associated with parotid mucoepidermoid carcinoma? A case report

Published:September 25, 2020DOI:


      To describe a patient with BRCA1 mutation, mucoepidermoid parotid, multiple breasts, and thyroid cancers.

      Case Report

      A women was diagnosed at 33-years-age with a triple-negative breast cancer (right breast), at 43-years-age with a triple-negative breast cancer in left breast and at 53-years-age with a primary papillary-thyroid carcinoma. At 55-years-age, she was diagnosed with a primary mucoepidermoid carcinoma in right parotid, and concomitantly, her right nipple was affected by Paget's disease and a recurrent carcinoma in right breast (HR + /HER2 = 3 +). At 57-years-age, after the recurrence of a triple-negative breast cancer (left breast), a geneticist evaluated the patient's family history, including one stomach, one non-smoking-related lung, and two smoking-related laryngeal cancers. Genetic testing revealed a BRCA1 mutation (Chr17:41:251.867). The patient's daughter (a non-cancer patient) tested negative for the mutation. Both remain under medical supervision.


      We suggest that BRCA1 mutations are associated with non-breast and non-ovarian cancers such as salivary gland cancer.
      To read this article in full you will need to make a payment


        • Ewald IP
        • Cossio SL
        • Palmero EI
        • et al.
        BRCA1 and BRCA2 rearrangements in Brazilian individuals with hereditary breast and ovarian cancer syndrome.
        Genet Mol Biol. 2016; 39: 223-231
        • Kim H
        • Choi DH
        • Park W
        • et al.
        The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans.
        Hered Cancer Clin Pract. 2019; 117: 1
        • Shen TK
        • Teknos TN
        • Toland AE
        • Senter L
        • Nagy R
        Salivary gland cancer in BRCA-positive families: a retrospective review.
        JAMA Otolaryngol Head Neck Surg. 2014; 140: 1213-1217
        • Boukheris H
        • Curtis RE
        • Land CE
        • Dores GM
        Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States.
        Cancer Epidemiol Biomarkers Prev. 2009; 18: 2899-2906
        • Xu L
        • Doan PC
        • Wei Q
        • Li G
        • Sturgis EM
        Functional single-nucleotide polymorphisms in the BRCA1 gene and risk of salivary gland carcinoma.
        Oral Oncol. 2012; 48: 842-847
        • Fujii K
        • Watanabe R
        • Ando T
        • et al.
        Alterations in three biomarkers (estrogen receptor, progesterone receptor and human epidermal growth factor 2) and the Ki67 index between primary and metastatic breast cancer lesions.
        Biomed Rep. 2017; 7: 535-542
        • Schlatter RP
        • Matte U
        • Polanczyk CA
        • Koehler-Santos P
        • Ashton-Prolla P
        Costs of genetic testing: supporting Brazilian Public Policies for the incorporating of molecular diagnostic technologies.
        Genet Mol Biol. 2015; 38: 332-337
        • van Erkelens A
        • Derks L
        • Sie AS
        • et al.
        Lifestyle risk factors for breast cancer in BRCA1/2-mutation carriers around childbearing age.
        J Genet Couns. 2017; 26: 785-791
        • Wang K
        • McDermott JD
        • Schrock AB
        • et al.
        Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3 CA, and other actionable genomic alterations.
        Ann Oncol. 2017; 28: 748-753
        • Cheng M
        • Geng C
        • Tang T
        • Song Z
        Mucoepidermoid carcinoma of the breast: four case reports and review of the literature.
        Medicine (Baltimore). 2017; 96: e9385
        • Sherwell-Cabello S
        • Maffuz-Aziz A
        • Ríos-Luna NP
        • Pozo-Romero M
        • López-Jiménez PV
        • Rodriguez-Cuevas S
        Primary mucoepidermoid carcinoma of the breast.
        Breast J. 2017; 23: 753-755
        • Di Tommaso L
        • Foschini MP
        • Ragazzini T
        • et al.
        Mucoepidermoid carcinoma of the breast.
        Virchows Arch. 2004; 444: 13-19
        • Glisson B
        • Colevas AD
        • Haddad R
        • et al.
        HER2 expression in salivary gland carcinomas: dependence on histological subtype.
        Clin Cancer Res. 2004; 10: 944-946
        • Wang K
        • Russell JS
        • McDermott JD
        • Elvin JA
        • Khaira D
        • Johnson A
        Profiling of 149 salivary duct carcinomas, carcinoma ex pleomorphic adenomas, and adenocarcinomas, not otherwise specified reveals actionable genomic alterations.
        Clin Cancer Res. 2016; 22: 6061-6068
        • Bossi P
        • Ripamonti CB
        • Manoukian S
        • et al.
        MC13-0082 salivary gland cancer in two male BRCA gene mutation carriers.
        Eur J Cancer. 2013; 49: s34-s35
        • Irani S
        • Bidari-Zerehpoush F.
        BRCA1/2 mutations in salivary pleomorphic adenoma and carcinoma-ex-pleomorphic adenoma.
        J Int Soc Prev Community Dent. 2017; 7: 155-162